2YP.F - Health Catalyst, Inc.
| Previous Close | 10.20 |
| Open | 10.40 |
| Bid | 10.40 x N/A |
| Ask | 10.70 x N/A |
| Day's Range | 10.40 - 10.40 |
| 52 Week Range | 6.55 - 17.40 |
| Volume | |
| Avg. Volume | 0 |
| Market Cap | 596.551M |
| Beta (5Y Monthly) | 1.23 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -2.57 |
| Earnings Date | Aug 02, 2023 - Aug 07, 2023 |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 66.00 |
Simply Wall St.CEO & Director of Health Catalyst Picks Up 6.9% More Stock \
Investors who take an interest in Health Catalyst, Inc. ( NASDAQ:HCAT ) should definitely note that the CEO & Director...
ZacksCompared to Estimates, Health Catalyst (HCAT) Q1 Earnings: A Look at Key Metrics
While the top- and bottom-line numbers for Health Catalyst (HCAT) give a sense of how the business performed in the quarter ended March 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
- Zacks
Health Catalyst (HCAT) Tops Q1 Earnings and Revenue Estimates
Health Catalyst (HCAT) delivered earnings and revenue surprises of 225% and 3.81%, respectively, for the quarter ended March 2023. Do the numbers hold clues to what lies ahead for the stock?
GlobeNewswireHealth Catalyst Reports First Quarter 2023 Results
SALT LAKE CITY, May 09, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended March 31, 2023. “In the first quarter of 2023, I am pleased to share that we achieved strong performance across our business, including exceeding the mid-point of our quarterly guidance for both revenue and Adjusted EBITDA. This financial perfor
- GlobeNewswire
Health Catalyst to Announce First Quarter 2023 Operating Results and Host Conference Call on Tuesday, May 9, 2023
SALT LAKE CITY, April 25, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its first quarter 2023 operating results on Tuesday, May 9, 2023, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day. Conference Call Details The conference call can be accessed by dialing 800-225-9448 for U
- Simply Wall St.
There's Reason For Concern Over Health Catalyst, Inc.'s (NASDAQ:HCAT) Price
There wouldn't be many who think Health Catalyst, Inc.'s ( NASDAQ:HCAT ) price-to-sales (or "P/S") ratio of 2.6x is...
ZacksDoes Health Catalyst (HCAT) Have the Potential to Rally 30.43% as Wall Street Analysts Expect?
The consensus price target hints at a 30.4% upside potential for Health Catalyst (HCAT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
ZacksZacks Industry Outlook Highlights Inspire Medical Systems, Olink Holding and Health Catalyst
Inspire Medical Systems, Olink Holding and Health Catalyst have been highlighted in this Industry Outlook article.
ZacksNextGen (NXGN) Riding on the Success of Cloud-Based Solution
NextGen's (NXGN) cloud-based healthcare technology solutions boost the company's prospect. Strong adoption of its services continues to boost revenues.
- GlobeNewswire
Health Catalyst to Participate in Upcoming Investor Conference
SALT LAKE CITY, March 07, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Bryan Hunt, Chief Financial Officer, and Adam Brown, Senior Vice President of Investor Relations and FP&A, will participate in the 44th Annual Raymond James Institutional Investors Conference, being held in Orlando, including a presentation on Wednesday, March 8, 2023 at 8:05a
Motley FoolWhy Health Catalyst Stock Rallied Wednesday Morning
Shares of Health Catalyst (NASDAQ: HCAT) charged sharply higher Wednesday morning, surging as much as 13.7%. For its fourth quarter, Health Catalyst generated revenue of $69.2 million, up 7% year over year. Health Catalyst also announced that Matthew Kolb, executive vice president and chief operating officer of Carle Health, would be joining its board of directors effective July 1.
- Thomson Reuters StreetEvents
Q4 2022 Health Catalyst Inc Earnings Call
Q4 2022 Health Catalyst Inc Earnings Call
- Zacks
Health Catalyst (HCAT) Reports Q4 Loss, Tops Revenue Estimates
Health Catalyst (HCAT) delivered earnings and revenue surprises of 50% and 1.16%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
- GlobeNewswire
Health Catalyst Reports Fourth Quarter and Year End 2022 Results
SOUTH JORDAN, Utah, Feb. 28, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter and year ended December 31, 2022. “In the fourth quarter of 2022, I am pleased to share that we achieved strong performance across our business, including exceeding the mid-point of our quarterly guidance for both revenue and Adjusted EBITDA. For
- GlobeNewswire
Health Catalyst to Announce Fourth Quarter and Full Year 2022 Operating Results and Host Conference Call on Tuesday, February 28, 2023
SALT LAKE CITY, Feb. 14, 2023 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its fourth quarter and full year 2022 operating results on Tuesday, February 28, 2023, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day. Conference Call Details The conference call can be accessed by dialin
Zacks3 Medical Info Systems Stocks Braving Industry-wide Headwinds
Zacks Medical Info Systems industry stocks like 10x Genomics (TXG), NextGen Healthcare (NXGN) and Health Catalyst (HCAT) are expected to gain as COVID-19 severity fades.
Motley Fool3 Top Tech Stocks That Could Help Make You Rich by Retirement
Tech stocks had as difficult a year as any sector in 2022, with the Nasdaq-100 tech index falling more than 39% over the past year. It's hard to find tech stocks, which are known for their growth, that weren't hit by falling share prices. Health Catalyst (NASDAQ: HCAT), Oracle (NYSE: ORCL), and Microsoft (NASDAQ: MSFT) are all poised to bounce back this year because their financials never really faltered, despite negative market sentiment for the sector.
- Simply Wall St.
Does This Valuation Of Health Catalyst, Inc. (NASDAQ:HCAT) Imply Investors Are Overpaying?
In this article we are going to estimate the intrinsic value of Health Catalyst, Inc. ( NASDAQ:HCAT ) by projecting its...
ZacksDoes Health Catalyst (HCAT) Have the Potential to Rally 61% as Wall Street Analysts Expect?
The consensus price target hints at a 61.5% upside potential for Health Catalyst (HCAT). While empirical research shows that this sought-after metric is hardly effective, an upward trend in earnings estimate revisions could mean that the stock will witness an upside in the near term.
- Simply Wall St.
CEO & Director Daniel Burton Just Bought 42% More Shares In Health Catalyst, Inc. (NASDAQ:HCAT)
Those following along with Health Catalyst, Inc. ( NASDAQ:HCAT ) will no doubt be intrigued by the recent purchase of...
- Simply Wall St.
Health Catalyst Third Quarter 2022 Earnings: US$0.84 loss per share (vs US$0.82 loss in 3Q 2021)
Health Catalyst ( NASDAQ:HCAT ) Third Quarter 2022 Results Key Financial Results Revenue: US$68.4m (up 11% from 3Q...
Motley FoolWhy Shares of Health Catalyst Popped 23.34% on Wednesday
Shares of Health Catalyst (NASDAQ: HCAT), jumped 23.34% on Wednesday. The company, which provides data and analytic solutions to healthcare companies, released its third-quarter earnings after the market closed on Tuesday. The company reported revenue of $68.4 million, up 11%, year over year, led by a 15% jump in revenue from its technology segment.
ZacksHealth Catalyst (HCAT) Reports Q3 Loss, Tops Revenue Estimates
Health Catalyst (HCAT) delivered earnings and revenue surprises of 35% and 2.25%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
GlobeNewswireHealth Catalyst Reports Third Quarter 2022 Results
SALT LAKE CITY, Nov. 08, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today reported financial results for the quarter ended September 30, 2022. “In the third quarter of 2022, I am pleased to share that we achieved strong performance across our business, including exceeding the mid-point of our quarterly guidance for both revenue and Adjusted EBITDA, and, based on an
- GlobeNewswire
Health Catalyst to Announce Third Quarter 2022 Operating Results and Host Conference Call on Tuesday, November 8, 2022
SALT LAKE CITY, Oct. 26, 2022 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, will release its third quarter 2022 operating results on Tuesday, November 8, 2022, after market close. In conjunction, the company will host a conference call to review the results at 5 p.m. E.T. on the same day. Conference Call Details The conference call can be accessed by dialing (800) 225-9448
